Lian, Zhaorui, Liu, Jie, Li, Li, Li, Xianxing, Tufan, N Lale Satiroglu, Clayton, Marcy, Wu, Meng-Chao, Wang, Hong-Yang, Arbuthnot, Patrick, Kew, Michael, and Feitelson, Mark A
Hepatitis B x antigen (HB x Ag) is a trans-activating protein that may be involved in hepatocarcinogenesis, although few natural effectors of HB x Ag that participate in this process have been identified. To identify additional effectors, whole cell RNA isolated from HB x Ag-positive and HB x Ag-negative HepG2 cells were compared by polymerase chain reaction select cDNA subtraction, and one clone, upregulated gene, clone 11 (URG11), was chosen for further characterization. Elevated levels of URG11 mRNA and protein were observed in HB x Ag-positive compared to HB x Ag-negative HepG2 cells. Costaining was observed in infected liver (P0.01). URG11 stimulated cell growth in culture (P0.01), anchorage-independent growth in soft agar (P0.001), and accelerated tumor formation (P0.01), and yielded larger tumors (P0.02) in SCID mice injected subcutaneously with HepG2 cells. These data suggest that URG11 is a natural effector of HB x Ag that may promote the development of hepatocellular carcinoma.